临床肝胆病杂志2017，Vol.33Issue(3)：588-592,5.DOI:10.3969/j.issn.1001-5256.2017.03.042
抗炎保肝药在自身免疫性肝炎治疗中的应用进展
Advances in the application of anti-inflammatory and liver-protecting drugs in treatment of autoimmune hepatitis
摘要
Abstract
Autoimmune hepatitis (AIH) is the first liver disease which has proved responsive to gluc()orticoids,and the standard therapeutic method is hormone combined with azathioprine.Given that some patients fail to reach the standard of immunosuppressive therapy,and the long-term use of immunosuppressive therapy has many adverse effects,it is necessary to reasonably use anti-inflammatory and liver-protecting drugs to minimize the dose of immunosuppressants,control liver inflammation,reduce the damage of liver cells,and delay the progression of the disease.This paper reviews the advances in the application of anti-inflammatory and liver-protecting drugs in the treatment of AIH,in order to help clinicians make rational decisions.关键词
肝炎,自身免疫性/药物疗法/治疗/综述Key words
hepatitis, autoimmune/drug therapy/therapy/review分类
医药卫生引用本文复制引用
张红霞,周璐,王邦茂..抗炎保肝药在自身免疫性肝炎治疗中的应用进展[J].临床肝胆病杂志,2017,33(3):588-592,5.基金项目
国家自然科学基金资助项目(81470834) （81470834）
